These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28738289)

  • 1. Germinal center enhancement by extended antigen availability.
    Cirelli KM; Crotty S
    Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.
    Borrow P; Moody MA
    Immunol Rev; 2017 Jan; 275(1):62-78. PubMed ID: 28133804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.
    Havenar-Daughton C; Lee JH; Crotty S
    Immunol Rev; 2017 Jan; 275(1):49-61. PubMed ID: 28133798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.
    Cirelli KM; Carnathan DG; Nogal B; Martin JT; Rodriguez OL; Upadhyay AA; Enemuo CA; Gebru EH; Choe Y; Viviano F; Nakao C; Pauthner MG; Reiss S; Cottrell CA; Smith ML; Bastidas R; Gibson W; Wolabaugh AN; Melo MB; Cossette B; Kumar V; Patel NB; Tokatlian T; Menis S; Kulp DW; Burton DR; Murrell B; Schief WR; Bosinger SE; Ward AB; Watson CT; Silvestri G; Irvine DJ; Crotty S
    Cell; 2019 May; 177(5):1153-1171.e28. PubMed ID: 31080066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development.
    Niessl J; Kaufmann DE
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29921828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Lee JH; Sutton HJ; Cottrell CA; Phung I; Ozorowski G; Sewall LM; Nedellec R; Nakao C; Silva M; Richey ST; Torres JL; Lee WH; Georgeson E; Kubitz M; Hodges S; Mullen TM; Adachi Y; Cirelli KM; Kaur A; Allers C; Fahlberg M; Grasperge BF; Dufour JP; Schiro F; Aye PP; Kalyuzhniy O; Liguori A; Carnathan DG; Silvestri G; Shen X; Montefiori DC; Veazey RS; Ward AB; Hangartner L; Burton DR; Irvine DJ; Schief WR; Crotty S
    Nature; 2022 Sep; 609(7929):998-1004. PubMed ID: 36131022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses.
    Moysi E; Petrovas C; Koup RA
    Retrovirology; 2018 Aug; 15(1):54. PubMed ID: 30081906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host controls of HIV broadly neutralizing antibody development.
    Kelsoe G; Haynes BF
    Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
    Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
    Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
    Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High T
    Eldi P; Chaudhri G; Nutt SL; Newsome TP; Karupiah G
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for a multi-stage neutralizing antibody-based HIV vaccine.
    Andrabi R; Bhiman JN; Burton DR
    Curr Opin Immunol; 2018 Aug; 53():143-151. PubMed ID: 29775847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and specificity of broadly neutralizing antibodies against HIV.
    McCoy LE; Burton DR
    Immunol Rev; 2017 Jan; 275(1):11-20. PubMed ID: 28133814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint modulation enhances HIV-1 antibody induction.
    Bradley T; Kuraoka M; Yeh CH; Tian M; Chen H; Cain DW; Chen X; Cheng C; Ellebedy AH; Parks R; Barr M; Sutherland LL; Scearce RM; Bowman CM; Bouton-Verville H; Santra S; Wiehe K; Lewis MG; Ogbe A; Borrow P; Montefiori D; Bonsignori M; Anthony Moody M; Verkoczy L; Saunders KO; Ahmed R; Mascola JR; Kelsoe G; Alt FW; Haynes BF
    Nat Commun; 2020 Feb; 11(1):948. PubMed ID: 32075963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
    Pauthner M; Havenar-Daughton C; Sok D; Nkolola JP; Bastidas R; Boopathy AV; Carnathan DG; Chandrashekar A; Cirelli KM; Cottrell CA; Eroshkin AM; Guenaga J; Kaushik K; Kulp DW; Liu J; McCoy LE; Oom AL; Ozorowski G; Post KW; Sharma SK; Steichen JM; de Taeye SW; Tokatlian T; Torrents de la Peña A; Butera ST; LaBranche CC; Montefiori DC; Silvestri G; Wilson IA; Irvine DJ; Sanders RW; Schief WR; Ward AB; Wyatt RT; Barouch DH; Crotty S; Burton DR
    Immunity; 2017 Jun; 46(6):1073-1088.e6. PubMed ID: 28636956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts on T follicular helper cell dynamics in HIV infection.
    Pissani F; Streeck H
    Trends Immunol; 2014 Jun; 35(6):278-86. PubMed ID: 24703588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.
    Abbott RK; Lee JH; Menis S; Skog P; Rossi M; Ota T; Kulp DW; Bhullar D; Kalyuzhniy O; Havenar-Daughton C; Schief WR; Nemazee D; Crotty S
    Immunity; 2018 Jan; 48(1):133-146.e6. PubMed ID: 29287996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
    Poteet E; Lewis P; Chen C; Ho SO; Do T; Chiang S; Labranche C; Montefiori D; Fujii G; Yao Q
    Vaccine; 2016 Nov; 34(48):5886-5894. PubMed ID: 27997339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
    Yu HT; Tian D; Wang JY; Guo CX; Li Y; Wang X; Li D; Zhang FM; Zhuang M; Ling H
    PLoS One; 2014; 9(12):e115047. PubMed ID: 25546013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.